Madan, R. A., Mohebtash, M., Arlen, P. M., Vergati, M., Rauckhorst, M., Steinberg, S. M., . . . Gulley, J. L. (2012). Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: A phase 1 dose-escalation trial. Lancet Oncol.
Stile di citazione ChicagoMadan, Ravi A., et al. "Ipilimumab and a Poxviral Vaccine Targeting Prostate-specific Antigen in Metastatic Castration-resistant Prostate Cancer: A Phase 1 Dose-escalation Trial." Lancet Oncol 2012.
Citazione MLAMadan, Ravi A., et al. "Ipilimumab and a Poxviral Vaccine Targeting Prostate-specific Antigen in Metastatic Castration-resistant Prostate Cancer: A Phase 1 Dose-escalation Trial." Lancet Oncol 2012.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.